PNPLA3 genetic variants have influence over the status of liver diseases, ranging from simple steatosis to MASLD, MASH, cirrhosis, and HCC [26,30]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.